Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Siganaki, Marianna ^a   Koutsopoulos, Anastasios V ^b   Neofytou, Eirini ^a   Vlachaki, Eleni ^c   Psarrou, Maria ^a   Soulitzis, Nikolaos ^a   Pentilas, Nikolaos ^d   Schiza, Sophia ^c   Siafakas, Nikolaos M ^a,c   Tzortzaki, Eleni G ^a,c  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^d G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ACTIN; BUDESONIDE; FLUTICASONE; IPRATROPIUM BROMIDE; PROTEIN BCL 2; PROTEIN P53; TIOTROPIUM BROMIDE; TP53 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LYMPHOCYTE; MALE; PROTEIN EXPRESSION; SMOKING; WESTERN BLOTTING; CASE CONTROL STUDY; CHEMISTRY; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

AGED; APOPTOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PNEUMOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; SMOKING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 77954596271     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-46     Document Type: Article

References (36)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, . Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-55. 10.1164/rccm.200703-456SO, 17507545, Global Initiative for Chronic Obstructive Lung Disease.
2. Hodge S, Hodge G, Holmes M, Reynolds P. Increased peripheral blood T-cell apoptosis and decreased Bcl-2 in chronic obstructive pulmonary disease. Immunology and Cell Biology 2005, 83:160. 10.1111/j.1440-1711.2005.01317.x, 15748212.
3. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005, 25(3):447-54. 10.1183/09031936.05.00077604, 15738287.
4. Plataki M, Tzortzaki E, Rytila P, Makris D, Koutsopoulos A, Siafakas NM. Apoptotic mechanisms in the pathogenesis of COPD. Internat J COPD 2006, 1(2):161-171.
5. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006, 7:53. 10.1186/1465-9921-7-53, 1501017, 16571143.
6. Hodge S, Hodge G, Holmes M, et al. Apoptosis in COPD. Curr Respir Med Reviews 2005, 1:33-41.
7. Park JW, Ryter SW, Choi AM. Functional significance of apoptosis in chronic obstructive pulmonary disease. COPD 2007, 4(4):347-53. 10.1080/15412550701603775, 18027162.
8. Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 2001, 29:684-8. 10.1042/BST0290684, 11709054.
9. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003, 116:4077-85. 10.1242/jcs.00739, 12972501.
10. Martin DA, Elkon KB. Mechanisms of apoptosis. Rheum Dis Clin North Am 2004, 30(3):441-54. 10.1016/j.rdc.2004.04.008, 15261335.
11. Weaver CV, Liu S-P. Differentially expressed pro- and anti-apoptogenic genes in response to benzene exposure: Immunohistochemical localization of p53, Bag, Bad, Bax, Bcl-2 and Bcl-w in lung epithelia. Exper Toxicol Pathol 2008, 59:265-272.
12. Tzortzaki E, Siafakas N. A new hypothesis for the initiation of COPD. Eur Resp J 2009, 34(2):310-5.
13. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component?. Thorax 2003, 58:832-834. 10.1136/thorax.58.10.832, 1746486, 14514931.
14. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001, 163:737-744.
15. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003, 29:88-97. 10.1165/rcmb.2002-0228OC, 12600822.
16. Hodge S, Hodge G, Holmes M, et al. Apoptosis in COPD. Current Respiratory Medicine Reviews 2005, 1:33-41.
17. Jiménez-Ruiz C, Miravitlles M, Sobradillo V, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease?. Nicotine Tob Res 2004, 6(4):649-53. 10.1080/14622200410001727948, 15370161.
18. Vlachaki EM, Koutsopoulos AV, Tzanakis N, Neofytou E, Siganaki M, Drositis I, Moniakis A, Schiza S, Siafakas NM, Tzortzaki EG. Altered surfactant protein-A (SP-A) expression in type II pneumocytes in COPD. Chest 2010, 137(1):37-45. 10.1378/chest.09-1029, 19741063.
19. Mascaretti RS, Mataloun MM, Dolhnikoff M, Rebello CM. Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits. Clinics 2009, 64(11):1099-104. 10.1590/S1807-59322009001100010, 2780527, 19936184.
20. Ikeda K, Monden T, Kanoh T, Tsujie M, Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H, Monden M. Extraction and Analysis of Diagnostically Useful Proteins from Formalin-fixed, Paraffin-embedded Tissue Sections. J Histochem Cytochem 1998, 46:397-403.
21. Hodge S, Hodge G, Scicchitano R, et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003, 81:289-296. 10.1046/j.1440-1711.2003.t01-1-01170.x, 12848850.
22. Bratton DL, Henson PM. Autoimmunity and apoptosis: refusing to go quietly. Nat Med 2005, 11:26-27. 10.1038/nm0105-26, 15635442.
23. Henson PM, Cosgrove GP, Vandivier RW. Apoptosis and Cell Homeostasis in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2006, 3:512-518. 10.1513/pats.200603-072MS, 2647642, 16921132.
24. Weaver CV, Liu SP, Lu JF, Lin BS. The effects of benzene exposure on apoptosis in epithelial lung cells: localization by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) and the immunocytochemical localization of apoptosis-related gene products. Cell Biol Toxicol 2007, 23(3):201-20. 10.1007/s10565-006-0165-2, 17171516.
25. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 2005, 25:250-258. 10.1183/09031936.05.00023704, 15684288.
26. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004, 125:626-632. 10.1378/chest.125.2.626, 14769747.
27. de Souza PM, Lindsay MA. Apoptosis as a therapeutic target for the treatment of lung diseases. Curr Opin Pharmacol 2005, 5:232-237. 10.1016/j.coph.2005.01.012, 15907908.
28. Schleimer RP. Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium. Proc Am Thorac Soc 2004, 1:222-230. 10.1513/pats.200402-018MS, 16113438.
29. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009, 10:59. 2714501, 19566934.
30. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, . UPLIFT Study Investigators A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359(15):1543-54. 10.1056/NEJMoa0805800, 18836213, UPLIFT Study Investigators.
31. Vignola AM, Riccobono L, Profita M, Foresi A, Di Giorgi R, Guerrera D, Gjomarkaj M, Di Blasi P, Paggiaro PL. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma. Allergy 2005, 60(12):1511-7. 10.1111/j.1398-9995.2005.00827.x, 16266383.
32. Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect 2008, 116(6):799-805. 10.1289/ehp.10981, 2430237, 18560537.
33. Pahlavani MA, Vargas DA. Aging but not dietary restriction alters the activation-induced apoptosis in rat T cells. FEBS Lett 2001, 491:114-118. 10.1016/S0014-5793(01)02184-6, 11226431.
34. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005, 25:447-454. 10.1183/09031936.05.00077604, 15738287.
35. Makris D, Vrekoussis T, Izoldi M, Alexandra K, Katerina D, Dimitris T, Michalis A, Tzortzaki E, Siafakas NM, Tzanakis N. Increased apoptosis of neutrophils in induced sputum of COPD patients. Respir Med 2009, 103(8):1130-5. 10.1016/j.rmed.2009.03.002, 19329291.
36. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 2003, 285(2):L492-9.